Separator

Varma Labs: Employs State-of-the-Art Instrumentation & Advanced Testing Methodologies

Separator
Geeta Penmatsa,Co-Founder
Geeta Penmatsa, Co-Founder

The escalating impact of both communicable and non-communicable diseases in India stresses on the exigency for quality medicines that can substantially quash these diseases. Certainly, to exemplify the facet of exceptional quality, all pharmaceutical products must undergo rigorous testing and certification from genuine pharma testing laboratories. Positioning itself as a quality-oriented organization, Varma Labs Pvt. Ltd. caters to the testing needs of customers across its cGMP licensed laboratory furnished with state-of-the-art instrumentation.

To carry-out the testing processes, Varma Labs utilizes advanced testing methodologies that are in conformance with U.S. FDA regulations and U.S. Pharmacopoeia standards. Geeta Penmatsa, Co-Founder, Varma Labs, claims, “Besides highest quality chemistry data in the industry, we provide superior value-added customer convenience along with analytical method development & validations for new molecules”. Since the time of its incorporation in 2014, the firm has earned boundless fame as well as reliable and trustworthy client base in the Visakhapatnam Pharma Industry for its services
with unparalleled quality and accountability.

"Besides highest quality chemistry data in the industry, we provide superior value-added customer convenience along with analytical method development & validations for new molecules"

The core competencies of Varma Labs include analysis of raw materials & intermediates, elemental analysis, validation & implementation, isolation & characterization of impurities and intermediate product analysis. Through its analytical division, the firm also performs analytical method development for tablets, capsules, suspensions, injectables, ophthalmic, oral contraceptives and herbal products and also analytical method validations for single & combination products, both on qualitative & quantitative bases. In addition, it specializes in analytical tests for nutraceuticals, active herbal ingredients, APIs, vitamins, enzymes, amino acids, metals, solvent residues, structural characterization analysis, GMP & GLP auditing process, food testing as per the guidelines and training.

Varma Labs undertakes Reverse phase and Normal phase chromatographic techniques like (Assay, chromatographic purity and related substances, Enantiomeric purity by High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC), Residual solvents /Organic volatile impurities analysis by HSGC, elemental analysis by Inductively Coupled Plasma Mass Spectrometry(ICP-MS), Atomic
Absorption spectroscopy, Potentiometric and Argentometric analysis, XRD, DSC, CHNS, TGA, NMR, MASS, LC-MS, GC-MS, LC-MSMS, Preparative HPLC, UV/visible spectrophotometer, Polarimeter, Particle size distribution and FTIR.

The Linchpins
Geeta along with her sister Prasanna Lakshmi channelized their numerous ideas and dreams about their careers into setting-up Varma Labs, thereby demarcating as the first women entrepreneurs across the Indian pharmaceutical testing laboratory bracket. Geeta has in fact excellent analytical knowledge and almost ten years of experience in guiding and maintaining the overall formulation & method development for various products. Varma Labs’ greatest strength apart from its founders is its highly qualified and well experienced scientific team that focuses on continuous quality improvement and enhancement in order to obtain 100 percent client satisfaction. They also ascertain to abide by the built-up values that align with good laboratory practice, good manufacturing practice, and related regulatory requirements entailing Indian Pharmacopoeia(IP), British Pharmacopoeia (BP), United States Pharmacopoeia (USP), European Pharmacopoeia(EP), ICH and ISO 17025.

Currently, Varma Labs is working on rebranding its office with state-of-the-art infrastructure and power besides expansion of its services across other cities in India which will commence from March 2019.